fbpx

OPSENS ANNOUNCES CREDIT AGREEMENT WITH CIBC INNOVATION BANKING

OPSENS ANNOUNCES CREDIT AGREEMENT WITH CIBC INNOVATION BANKING Quebec City, Quebec, February 27, 2019 – Opsens Inc. (“Opsens”) (TSX:OPS) (OTCQX:OPSSF) ) is pleased to announce that it has entered into an $8 M credit agreement (the “Agreement”) with CIBC Innovation Banking (CIBC). […]

Read More…

ATTEND THE OPSENS SPONSORED LUNCH SYMPOSIUM AT CRT 2019

Attend the Opsens sponsored complimentary lunch educational symposium, “Coronary Physiology 2019: Covering All Your (Physiologic) Bases” at the CRT (Cardiovascular Research Technologies) 2019 Conference in Washington, DC. The OptoWire features a large nitinol core with excellent torque response and deliverability. With the […]

Read More…

OPSENS’ dPR OBTAINS CE MARKING TO SELL IN EUROPE

Quebec City, Quebec, January 9, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) has been granted CE marking for its diastolic pressure algorithm (“dPR”). Opsens’ dPR algorithm has been designed to assess intracoronary pressure with the heart at […]

Read More…

OPSENS – 50,000 PATIENTS DIAGNOSED WITH THE OPTOWIRE

Quebec City, Quebec, November 1st, 2018 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) has reached an important milestone with more than 50,000 patients assessed with the OptoWire™, a pressure guidewire used to measure Fractional Flow Reserve (“FFR”) to […]

Read More…

This website uses cookies to ensure you get the best experience on our website.